← Eichor
Study identifier: NCT06700096 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

Condition: Hemophilia B  ·  Sponsor: Biocad

PhasePhase 3
Planned participants24
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The aim of the study is to demonstrate non-inferiority of ANB-002 compared with preventive use of coagulation factor IX (FIX) in adult subjects with hemophilia B with FIX activity ≤2% and without FIX inhibitor. The study will have an open-label single-arm design.

This description comes directly from the study's public registry record.

Talk to the study team

Anna Eremeeva, MD PhD  ·  +7 (812) 380 49 34  ·  eremeevaav@biocad.ru

Always discuss trial participation with your own doctor first.

Locations (14)

Chelyabinsk Regional Clinical HospitalChelyabinsk, RussiaRecruiting
Federal State Budgetary Organization of Science "Kirov Research Institute of Hematology and Blood Transfusions of Federal Medical Biological agency"Kirov, RussiaRecruiting
Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Clinical Diagnostics for Hematology and Hemostasis Disorders)Moscow, RussiaRecruiting
Federal State Budgetary Institution "National Medical Research Centre for Hematology" of the Ministry of Health of Russian Federation (Department of Traumatology and Reconstructive and Restorative Orthopedics for Patients with Hemophilia)Moscow, RussiaRecruiting
Federal Budgetary Institution "Moscow City Clinical Hospital named after S. P. Botkin"Moscow, RussiaRecruiting
State Novosibirsk Regional Clinical HospitalNovosibirsk, RussiaRecruiting
State budgetary healthcare institution Leningrad Regional Clinical HospitalSaint Petersburg, RussiaRecruiting
Russian Research Institute of Hematology and Transfusiology Federal State Institution of Federal Medical and Biological AgencySaint Petersburg, RussiaRecruiting
Almazov National Medical Research CentreSaint Petersburg, RussiaRecruiting
Federal State Budgetary Educational Institution of Higher Education "Samara State Medical University" of the Ministry of Healthcare of the Russian FederationSamara, RussiaRecruiting
Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry of Healthcare of the Russian FederationUfa, RussiaRecruiting
King Chulalongkorn Memorial HospitalBangkok, ThailandNot Yet Recruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06700096